What were RPG Life Sciences Ltd's latest quarterly results?
RPG Life Sciences Ltd's latest quarterly results (Mar 2026) show
- PAT Growth YoY: -74.4% (insufficient_data)
- Revenue Growth YoY: +23.8%
- Operating Margin: 19.0% (volatile)
RPG Life Sciences Ltd: Why Is It Outperforming Nifty 500?
ActiveRS +26.0%Weak
In , RPG Life Sciences Ltd (Pharma - Formulators) is outperforming Nifty 500 with +26.0% relative strength. Fundamentals: Weak.
RPG Life Sciences Ltd Key Facts
- PE Ratio
- 36.3x
- Market Cap
- ₹4,074 Cr
- PAT Growth YoY
- -74%
- Revenue Growth YoY
- +24%
- OPM
- 19.0%
- RS vs Nifty 500
- +26.0%
What's Happening
🏛️DII accumulation — stake up 1.3%
Key Numbers
PAT Growth YoY
-74%
Insufficient Data
Revenue YoY
+24%
Insufficient Data
Operating Margin
19.0%
+100 bps YoY
PE Ratio
36.3
Current Price
₹2,463
Dividend Yield
0.81%
Fundamental Score
39/100
Weak
3Y PAT CAGR
-37%
Market Cap
4.1K Cr
Valuation
N/A12-Week Performance
Weekly presence in the outperformers list. Green = beating Nifty 500 by 10%+ that week.
12 weeks agoThis week
How Fast Is RPG Life Sciences Ltd Growing?
Revenue, profit and margin growth rates
| Metric | YoY | 3Y CAGR | Trend |
|---|---|---|---|
| Revenue | +24% | +8% | Insufficient Data |
| PAT (Net Profit) | -74% | -37% | Insufficient Data |
| OPM | 19.0% | +100 bps | Volatile |
Other Top Pharma - Formulators Stocks Beating Nifty 500
Frequently Asked Questions: RPG Life Sciences Ltd
Based on publicly available financial data. This is educational research, not investment advice.
Is RPG Life Sciences Ltd's profit growing or declining?
RPG Life Sciences Ltd's profit is declining with an insufficient_data trend.
- PAT Growth YoY: -74.4% (latest quarter)
- PAT Growth QoQ: +36.4% (sequential)
- 3-Year PAT CAGR: -37.2%
- Trend: Insufficient_data — consistent growth pattern
What is RPG Life Sciences Ltd's revenue growth trend?
RPG Life Sciences Ltd's revenue growth trend is insufficient_data.
- Revenue Growth YoY: +23.8%
- Revenue Growth QoQ: -1.7% (sequential)
- 3-Year Revenue CAGR: +8.4%
How is RPG Life Sciences Ltd's operating margin trending?
RPG Life Sciences Ltd's operating margin is volatile.
- Current OPM: 19.0%
- OPM Change YoY: +1.0% basis points
- OPM Change QoQ: -3.0% basis points
What is RPG Life Sciences Ltd's 3-year profit and revenue CAGR?
RPG Life Sciences Ltd's long-term compounding rates
- 3-Year Profit CAGR: -37.2%
- 3-Year Revenue CAGR: +8.4%
Is RPG Life Sciences Ltd's growth accelerating or decelerating?
RPG Life Sciences Ltd's earnings growth is insufficient_data with improving on a sequential basis.
- YoY Acceleration: -37.3% bps
- Sequential Acceleration: +76.9% bps
What is RPG Life Sciences Ltd's current PE ratio?
RPG Life Sciences Ltd's current PE ratio is 36.3x.
- Current PE: 36.3x
- Market Cap: 4.1K Cr
- Dividend Yield: 0.81%
What is RPG Life Sciences Ltd's price-to-book ratio?
RPG Life Sciences Ltd's price-to-book ratio is 6.7x.
- Price-to-Book (P/B): 6.7x
- Book Value per Share: ₹366
- Current Price: ₹2463
Is RPG Life Sciences Ltd a fundamentally strong company?
RPG Life Sciences Ltd is rated Weak with a fundamental score of 38.86/100. This score is calculated from objective financial metrics
- Revenue Growth YoY: +23.8% (10% weight)
- PAT Growth YoY: -74.4% (10% weight)
- PAT Growth QoQ: +36.4% (10% weight)
- Margins stable (10% weight)
Is RPG Life Sciences Ltd debt free?
RPG Life Sciences Ltd has a debt-to-equity ratio of N/A.
- Total Debt: ₹20 Cr
What is RPG Life Sciences Ltd's return on equity (ROE) and ROCE?
RPG Life Sciences Ltd's return ratios over recent years
- FY2026: ROCE 26.0%
Is RPG Life Sciences Ltd's cash flow positive?
RPG Life Sciences Ltd's operating cash flow is positive (FY2026).
- Cash from Operations (CFO): ₹56 Cr
- Free Cash Flow (FCF): ₹142 Cr
- CFO/PAT Ratio: 49% (weak cash conversion)
What is RPG Life Sciences Ltd's dividend yield?
RPG Life Sciences Ltd's current dividend yield is 0.81%.
- Dividend Yield: 0.81%
- Current Price: ₹2463
Who holds RPG Life Sciences Ltd shares — promoters, FII, DII?
RPG Life Sciences Ltd's shareholding pattern (Mar 2026)
- Promoters: 73.0%
- FII (Foreign): 0.9%
- DII (Domestic): 7.5%
- Public: 18.7%
Is promoter holding increasing or decreasing in RPG Life Sciences Ltd?
RPG Life Sciences Ltd's promoter holding has remained stable recently.
- Current Promoter Holding: 73.0% (Mar 2026)
- Previous Quarter: 73.0% (Dec 2025)
- Change: 0.00% (stable)
How long has RPG Life Sciences Ltd been outperforming Nifty 500?
RPG Life Sciences Ltd has been outperforming Nifty 500 for 2 consecutive weeks, indicating early-stage outperformance.
Is RPG Life Sciences Ltd a new momentum entry or an established outperformer?
RPG Life Sciences Ltd is an established outperformer with 2 weeks of consecutive Nifty 500 outperformance.
Is RPG Life Sciences Ltd worth studying for long term investment?
Based on quantitative research signals, here is why RPG Life Sciences Ltd may be worth studying
- Cash flow is positive — CFO ₹56 Cr
What is the investment thesis for RPG Life Sciences Ltd?
RPG Life Sciences Ltd investment thesis summary:
Research Signals (Bull Case)
- Revenue growing at +23.8% YoY
What is the future outlook for RPG Life Sciences Ltd?
RPG Life Sciences Ltd's forward outlook based on current data signals
- Earnings Trend: insufficient_data
- Revenue Trend: insufficient_data
- Margin Trend: volatile
The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.